Patent US4357420A successfully refreshed from Google Patents.
US4357420A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bioluminescence methods for enzymatic determinations
Assignee: United States Department of Energy
•
Filing: 1981-04-28
•
Granted: 1982-11-02
•
Expires: 2001-04-28
Abstract
Abstract An enzymatic method for continuous, on-line and rapid detection of diagnostically useful biomarkers, which are symptomatic of disease or trauma-related tissue damage, is disclosed. The method is characterized by operability on authentic samples of complex biological fluids which contain the biomarkers.
Inventors
- 👤 William D. Bostick
- 👤 Mark S. Denton
- 👤 Stanley R. Dinsmore
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 21:55
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/66; C12Q1/26; C12Q1/32; C12Q1/48; C12Q1/50; Y; Y10; Y10S; Y10S435/00; Y10S435/808
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
109 words
A nonreferenced method for continuous, on-line and rapid detection of diagnostically useful biomarkers, which are symptomatic of disease or trauma-related tissue damage, said method characterized by operability on an authentic sample of complex biological fluids, containing a plurality of said biomarkers, comprising, in combination, the steps of: contacting a predetermined amount of the sample with an enzymatically effective amount of reactants to generate a specific bioluminescent emission correlatable to the concentration of a specific diagnostically useful biomarker isolated by liquid chromatography from said biomarker plurality; and monitoring the emission intensity to determine the specific biomarker concentration in a fluorometer characterized by the absence of an excitation source and filters.
Claim 2
Dependent Claim
109 words
A nonreferenced method for continuous, on-line and rapid detection of diagnostically useful biomarkers, which are symptomatic of disease or trauma-related tissue damage, said method characterized by operability on an authentic sample of complex biological fluids, containing a plurality of said biomarkers, comprising, in combination, the steps of: contacting a predetermined amount of the sample with an enzymatically effective amount of reactants to generate a specific bioluminescent emission correlatable to the concentration of a specific diagnostically useful biomarker isolated by liquid chromatography from said biomarker plurality; and monitoring the emission intensity to determine the specific biomarker concentration in a fluorometer characterized by the absence of an excitation source and filters.
Claim 3
Dependent Claim
13 words
The method of claim 1 wherein the biomarker of interest is creatine kinase.
Claim 4
Dependent Claim
13 words
The method of claim 1 wherein the biomarker of interest is lactate dehydrogenase.
Claim 5
Dependent Claim
15 words
The method of claim 1 wherein the bioluminescent emission is a directly produced reaction product.
Claim 6
Dependent Claim
26 words
The method of claim 1 wherein the bioluminescent emission is a reaction product enzymatically coupled to the formation of the reduced form of NAD or NADP.
Claim 7
Dependent Claim
166 words
A nonreferenced and automated method for quantifying at least one of a complex mixture of tissue-specific isoenzymes in an aqueous media comprising the steps of: (a) resolving the complex mixture into discernable isoenzyme components by liquid chromatography; (b) contacting a predetermined amount of the resolved components with at least one or more reactants in an amount effective to produce an ordered sequence of reactions wherein: (A) in a first reaction, at least one resolved component produces as a product the reduced form of NAD or NADP; (B) in a second reaction, said reduced form is oxidized in the presence of flavin oxidoreductase to produce the reduced form of riboflavin and NAD or NADP; and (C) in a third reaction, the reduced form of riboflavin is oxidized in the presence of oxygen, dodecanal, and bacterial luciferase to produce a bioluminescent emission accurately confirming the presence of the at least one resolved component; and (c) correlating said emission to the concentration of the at least one resolved component.
Claim 8
Dependent Claim
166 words
A nonreferenced and automated method for quantifying at least one of a complex mixture of tissue-specific isoenzymes in an aqueous media comprising the steps of: (a) resolving the complex mixture into discernable isoenzyme components by liquid chromatography; (b) contacting a predetermined amount of the resolved components with at least one or more reactants in an amount effective to produce an ordered sequence of reactions wherein: (A) in a first reaction, at least one resolved component produces as a product the reduced form of NAD or NADP; (B) in a second reaction, said reduced form is oxidized in the presence of flavin oxidoreductase to produce the reduced form of riboflavin and NAD or NADP; and (C) in a third reaction, the reduced form of riboflavin is oxidized in the presence of oxygen, dodecanal, and bacterial luciferase to produce a bioluminescent emission accurately confirming the presence of the at least one resolved component; and (c) correlating said emission to the concentration of the at least one resolved component.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-11-01 | 1986-05-03 | 1986-11-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-11-01 | 1990-05-03 | 1990-11-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-11-01 | 1994-05-03 | 1994-11-02 | $7700.00 | Window Closed / Lapsed |